Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 SEK)

NET PROFIT (x1000 SEK)

Share

Biopharma AS

Closing information (x1000 SEK)

Closing information 2023/12 2022/12 2021/12
Turnover 23,998 More Arrow 28,170 Less Arrow 26,795
Financial expenses 0 Equal arrow 0 Equal arrow 0
Earnings before taxes 3,701 Less Arrow 923 More Arrow 3,775
Total assets 11,104 More Arrow 17,225 Less Arrow 15,534
Current assets 11,104 More Arrow 17,225 Less Arrow 15,534
Current liabilities 4,513 More Arrow 12,969 Less Arrow 12,302
Equity capital 5,510 Less Arrow 2,810 Less Arrow 1,480
- share capital 30 More Arrow 32 Less Arrow 31

Financial ratios

Fiscal year 2023/12 2022/12 2021/12
Solvency 49.6% Less Arrow 16.3% Less Arrow 9.5%
Turnover per employee
Profit as a percentage of turnover 15.4% Less Arrow 3.3% More Arrow 14.1%
Return on assets (ROA) 33.3% Less Arrow 5.4% More Arrow 24.3%
Current ratio 246.0% Less Arrow 132.8% Less Arrow 126.3%
Return on equity (ROE) 67.2% Less Arrow 32.8% More Arrow 255.1%
Change turnover -2,305 More Arrow 544 Less Arrow -5,453
Change turnover % -9% More Arrow 2% Less Arrow -17%
Chg. No. of employees
Chg. No. of employees %

Total value of public sale

Fiscal year 2023/12 2022/12 2021/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.